Video | April 13, 2021

Achieving A Flexible, Integrated And Sustainable Cryogenic Cold Chain Ecosystem

Source: Cytiva

Panelists review the evolution of the cryogenic cold chain needs in this decade, with specific emphasis on what it takes to create a full ecosystem, taking into account the considerations all key stakeholders need and how we should be thinking about sustainable as well as integrated solutions.

During this discussion, our panel will examine the cell and gene therapy solutions that have been designed to overcome challenges in the cryogenic cold chain ecosystem. Looking ahead, we will consider what continued developments are needed to ensure end-to-end sustainability of this ecosystem.

By highlighting lessons learned from the COVID-19 pandemic, panelists will also emphasize the importance of both sustainable and automated cell and gene therapy processing to maintain a continuous supply chain and deliver critical treatments to clinic.

Panelists

  • Beth Webb, Commercial GM, Cell & Gene Therapy, Cytiva
  • Dr. Stephen Ward, Chief Manufacturing Officer, Cell and Gene Therapy Catapult
  • David Brochu, Chief Technical Officer, Autolus Therapeutics
  • Alex Guite, Ph.D, Vice President, Services and Alliances, AmerisourceBergen World Courier & ICS
VIEW THE VIDEO!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: